These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 25203323)
1. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression. Wang Y; Chen D; Qian H; Tsai YS; Shao S; Liu Q; Dominguez D; Wang Z Cancer Cell; 2014 Sep; 26(3):374-389. PubMed ID: 25203323 [TBL] [Abstract][Full Text] [Related]
2. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism. Chang HL; Lin JC Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447 [TBL] [Abstract][Full Text] [Related]
3. RNA-Binding Motif 4 (RBM4) Suppresses Tumor Growth and Metastasis in Human Gastric Cancer. Yong H; Zhao W; Zhou X; Liu Z; Tang Q; Shi H; Cheng R; Zhang X; Qiu Z; Zhu J; Feng Z Med Sci Monit; 2019 May; 25():4025-4034. PubMed ID: 31145716 [TBL] [Abstract][Full Text] [Related]
4. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer. Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261 [TBL] [Abstract][Full Text] [Related]
5. RBM4-regulated alternative splicing suppresses tumorigenesis. Cancer Discov; 2014 Nov; 4(11):1253. PubMed ID: 25367940 [TBL] [Abstract][Full Text] [Related]
6. Nuclear Aurora kinase A switches m Li S; Qi Y; Yu J; Hao Y; He B; Zhang M; Dai Z; Jiang T; Li S; Huang F; Chen N; Wang J; Yang M; Liang D; An F; Zhao J; Fan W; Pan Y; Deng Z; Luo Y; Guo T; Peng F; Hou Z; Wang C; Zheng F; Xu L; Xu J; Wen Q; Jin B; Wang Y; Liu Q Signal Transduct Target Ther; 2022 Apr; 7(1):97. PubMed ID: 35361747 [TBL] [Abstract][Full Text] [Related]
7. RBM4 modulates the proliferation and expression of inflammatory factors via the alternative splicing of regulatory factors in HeLa cells. Wang WY; Quan W; Yang F; Wei YX; Chen JJ; Yu H; Xie J; Zhang Y; Li ZF Mol Genet Genomics; 2020 Jan; 295(1):95-106. PubMed ID: 31489484 [TBL] [Abstract][Full Text] [Related]
8. Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events. Lin JC; Lin CY; Tarn WY; Li FY RNA; 2014 Oct; 20(10):1621-31. PubMed ID: 25140042 [TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma. Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587 [TBL] [Abstract][Full Text] [Related]
10. Loss of Pnn expression results in mouse early embryonic lethality and cellular apoptosis through SRSF1-mediated alternative expression of Bcl-xS and ICAD. Leu S; Lin YM; Wu CH; Ouyang P J Cell Sci; 2012 Jul; 125(Pt 13):3164-72. PubMed ID: 22454513 [TBL] [Abstract][Full Text] [Related]
11. Transcriptome-wide targets of alternative splicing by RBM4 and possible role in cancer. Markus MA; Yang YH; Morris BJ Genomics; 2016 Apr; 107(4):138-44. PubMed ID: 26898347 [TBL] [Abstract][Full Text] [Related]
12. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer. de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231 [TBL] [Abstract][Full Text] [Related]
13. USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4. Liao XH; Wang Y; Zhong B; Zhu SY Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3143-3151. PubMed ID: 32271432 [TBL] [Abstract][Full Text] [Related]
14. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers. Cohen-Eliav M; Golan-Gerstl R; Siegfried Z; Andersen CL; Thorsen K; Ørntoft TF; Mu D; Karni R J Pathol; 2013 Mar; 229(4):630-9. PubMed ID: 23132731 [TBL] [Abstract][Full Text] [Related]
15. Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation. Ji L; Ni T; Shen Y; Xue Q; Liu Y; Chen B; Cui X; Lv L; Yu X; Cui Y; Lu X; Chen J; Mao G; Wang Y J Mol Histol; 2014 Oct; 45(5):573-82. PubMed ID: 24952301 [TBL] [Abstract][Full Text] [Related]
16. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC. Das S; Anczuków O; Akerman M; Krainer AR Cell Rep; 2012 Feb; 1(2):110-7. PubMed ID: 22545246 [TBL] [Abstract][Full Text] [Related]
17. RBM4 regulates cellular senescence via miR1244/SERPINE1 axis. Wang L; Zhang X; Sheng J; Chen L; Zhi L; Zheng Q; Qi Y; Wang L; Zhang J; Zhao J; Wang Y; Liu SX; Sun MZ; Zhang W Cell Death Dis; 2023 Jan; 14(1):27. PubMed ID: 36639375 [TBL] [Abstract][Full Text] [Related]
18. RBM25 depletion suppresses the growth of colon cancer cells through regulating alternative splicing of MNK2. Zhi L; Chen C; Zhang G; Huang T; He W; Zhang J; Chen D; Liu J; Zhao J; Qi Y; Wang G; Zhang W; Wang Y Sci China Life Sci; 2024 Oct; 67(10):2186-2197. PubMed ID: 39110401 [TBL] [Abstract][Full Text] [Related]
19. The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival. Naro C; Barbagallo F; Chieffi P; Bourgeois CF; Paronetto MP; Sette C Nucleic Acids Res; 2014 Mar; 42(5):3218-27. PubMed ID: 24369428 [TBL] [Abstract][Full Text] [Related]
20. Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a. Shultz JC; Goehe RW; Wijesinghe DS; Murudkar C; Hawkins AJ; Shay JW; Minna JD; Chalfant CE Cancer Res; 2010 Nov; 70(22):9185-96. PubMed ID: 21045158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]